# Ferring Microbiome Inc. - Inspection Records

Source: https://www.keypedia.com/companies/ferring-microbiome-inc/860d4130-d93a-4017-97ca-30033280de85

> Inspection records and compliance data for Ferring Microbiome Inc. in Roseville, Minnesota. Access full analysis and detailed observations.

---

## Details

- Name: Ferring Microbiome Inc.
- FEI Number: 3012047188
- City: Roseville
- State: Minnesota
- Country Name: United States
- Address Line 1: 2660 Patton Rd
- Zip Code: 55113

## Related Documents

- [483 - Ferring Microbiome Inc. - 2025-06-26](https://www.keypedia.com/records/483/ferring-microbiome-inc/c6b59cda-48e0-41a8-8319-5f43294a94c8) — source: FDA, date: June 26, 2025
- [FDA Inspection 1275160 - Ferring Microbiome Inc. - 2025-06-26](https://www.keypedia.com/records/fda_inspections/ferring-microbiome-inc/438eac5d-4283-4c63-8fa7-4387b52e9f93) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 26, 2025
- [FDA Inspection 1275160 - Ferring Microbiome Inc. - 2025-06-26](https://www.keypedia.com/records/fda_inspections/ferring-microbiome-inc/7225d291-0a95-4838-a506-a1222e594463) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 26, 2025
- [FDA Inspection 1171839 - Ferring Microbiome Inc. - 2022-06-06](https://www.keypedia.com/records/fda_inspections/ferring-microbiome-inc/8738114b-c6fc-4e95-bb00-af5439cd2f4d) — classification: No Action Indicated (NAI), source: FDA, date: June 6, 2022
- [FDA Inspection 1182286 - Ferring Microbiome Inc. - 2022-05-06](https://www.keypedia.com/records/fda_inspections/ferring-microbiome-inc/e5c69974-e264-436d-ad6e-b96c1bba5d30) — classification: No Action Indicated (NAI), source: FDA, date: May 6, 2022
- [483 - Ferring Microbiome Inc. - 2018-07-09](https://www.keypedia.com/records/483/ferring-microbiome-inc/db49ed03-9464-40cf-9ac3-596cff6324b6) — source: FDA, date: July 9, 2018
- [FDA Inspection 1058316 - Ferring Microbiome Inc. - 2018-07-09](https://www.keypedia.com/records/fda_inspections/ferring-microbiome-inc/836e3085-89f1-47a3-9bce-4f609a1ac8c1) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 9, 2018

## Related Companies

- [Qilu Antibiotics Pharmaceutical Co. , Ltd.](https://www.keypedia.com/companies/qilu-antibiotics-pharmaceutical-co-ltd/f1c696c7-317f-4fb9-92a1-df8381af004c)
- [Latina Pharma S.p.A.](https://www.keypedia.com/companies/latina-pharma-spa/9cb7e758-39a0-4b4c-bfad-93d1468f5d38)
- [Patheon Pharmaceuticals Inc.](https://www.keypedia.com/companies/patheon-pharmaceuticals-inc/f1ef6b53-3c20-4c22-9ef3-fd05fdb9f35b)
- [Changzhou Pharmaceutical Factory](https://www.keypedia.com/companies/changzhou-pharmaceutical-factory/eea165e1-3df2-47c8-94b9-e8400af46bc4)
- [Gland Pharma Limited](https://www.keypedia.com/companies/gland-pharma-limited/9d02bb1e-32f9-45c5-9b90-f52622553c63)
- [Reliance Life Sciences Private Limited](https://www.keypedia.com/companies/reliance-life-sciences-private-limited/14b16d70-e482-4647-a231-4eb4a1aab98f)
- [Sumitomo Dainippon Pharma Co., Ltd.](https://www.keypedia.com/companies/sumitomo-dainippon-pharma-co-ltd/40ead027-5fd5-4deb-a37b-40301cffd612)
- [FUJIFILM Diosynth Biotechnologies Denmark ApS](https://www.keypedia.com/companies/fujifilm-diosynth-biotechnologies-denmark-aps/513b3c42-1517-43bc-936a-d3edd26bed70)
- [Baxalta US Inc.](https://www.keypedia.com/companies/baxalta-us-inc/dd00e45b-9175-4b17-82d5-b189a034a97f)
- [Eli Lilly & Company](https://www.keypedia.com/companies/eli-lilly-company/fc56eed7-d261-4de3-865e-c2aa54162adf)

## Related Officers

- [investigator](https://www.keypedia.com/people/nicole-c-victoria/8c5f8060-452f-4fe5-a43f-a448ec020e60)
- [Scott T. Ballard](https://www.keypedia.com/people/scott-t-ballard/09b2ae9a-3b30-45bd-bac1-437365e938da)
- [Laurel A. Beer](https://www.keypedia.com/people/laurel-a-beer/0ac1e74f-0ff6-4db6-a0e8-0c3fb013720e)